Exane Derivatives’s Vanguard FTSE Europe ETF VGK Stock Holding History
Bought
Maintained
Sold
Other funds holding VGK
MG
BTI
Exane Derivatives's VGK Position: Q2 2022 in Review
Exane Derivatives sold out of Vanguard FTSE Europe ETF (VGK) in Q2 2022, closing a stake of 10,566 shares — an estimated $658K sold.
Exane Derivatives first reported a position in VGK in Q4 2020 and held it in 5 quarters. The position peaked at $720K in Q1 2021. 594 funds tracked by Wall St. Rank hold VGK as of Q2 2022.
- Exane Derivatives reported no remaining Vanguard FTSE Europe ETF position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 10,566 Vanguard FTSE Europe ETF shares in Q2 2022, an estimated $658K.
- Exane Derivatives first reported a position in Vanguard FTSE Europe ETF in Q4 2020 and held it in 5 quarters.
- Exane Derivatives's Vanguard FTSE Europe ETF position peaked at $720K in Q1 2021.
- 594 funds tracked by Wall St. Rank held Vanguard FTSE Europe ETF as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.